[1]STACEY MILLS.病理医师实用组织学[M].薛德彬,陈健,译.第5版.北京:北京科技出版社,2021:341-343.
STACEY MILLS.Histology for pathologist[M].XUE DB,CHEN J,translated.Fifth edition.Beijing:Beijing Science & Technology Press,2021:341-343.
[2]赵桂秋,孙为荣.眼科病理学[M].第2版.北京:人民卫生出版社,2014:374-379.
ZHAO GQ,SUN WR.Ophthalmic pathology[M].Second edition.Beijing:People's Health Publishing House,2014:374-379.
[3]HUANG M,PATEL J,PATEL BC.Optic nerve glioma[DB/OL].In:StatPearls.Treasure Island (FL):StatPearls Publishing,2022 (2022-5-24)[2023-8-22].https://www.ncbi.nlm.nih.gov/ books/NBK557878/.PMID:32491801.
[4]陆燕,魏锐利.视神经原发性肿瘤及治疗新进展[J].中国实用眼科杂志,2011,29(09):885-888.
LU Yan,WEI Ruili.Primary tumor of optic nerve and new progress in the treatment [J].Chinese Journal of Practical Ophthalmology,2011,29(09):885-888.
[5]GROSSNIKLAUS HE,EBERHART CG,KIVELA TT,et al.WHO classification of tumours of the eye[M].4th Edition.Lyon:IARC,2018:136-140.
[6]TOOLEY AA,RASOOI N,CAMPBELL A,et al.Acute angle plication of optic nerve glioma as a mechanism of rapidly progressive visual loss [J].Orbit,2021,40(1):30-33.
[7]ALABIAD CR,SHAH VS,EATZ TA,et al.Malignant optic nerve glioma in a young woman with 7 year follow up without recurrence[J].Am J Ophthalmol Case Rep,2020,19:100862.
[8]SHAPEY J,DANESH-MEYER HV,KAYE AH.Diagnosis and management of optic nerve glioma[J].J Clin Neurosci,2011,18(12):1585-1591.
[9]孙为荣,王传富.眼科病理学[M].北京:人民卫生出版社,1997:540.
SUN WR,WANG CF.Ophthalmic pathology[M].Beijing:People's Health Publishing House,1997:540.
[10]MYRON YANOFF,JOSEPH SASSANI.Ocular pathology[M].Eighth Edition,Amsterdam:Elsevier Science,2018:513,515.
[11] CAMPBELL AA,GARTRELL-CORRADO RD,MANSUKHANI M,et al.SETD2 mutation in an aggressive optic nerve glioma[J].JAMA Ophthalmol,2020,138(1):102-104.
[12]韩晓艺,李锐,张颖,等.视神经胶质瘤临床病理及BRAF基因融合特点分析[J].临床与实验病理学杂志,2021,37(11):1358-1361.
HAN XY,LI R,ZHANG Y,et al.Analysis of clinicopathological and BRAF gene fusion characteristics of optic glioma [J].Journal of Clinical and Experimental Pathology,2021,37(11):1358-1361.
[13]韩希峰,张明坤,刘广存.1 型神经纤维瘤病相关胶质瘤发病机制研究及治疗进展[J].山东医药,2020,60(15):107-111.
HAN XF,ZHANG MK,LIU GC.Progress in the pathogenesis and treatment of neurofibromatosis type 1-related glioma [J].Shandong Medical Journal,2020,60(15):107-111.
[14]任婷婷,马建民.视神经胶质瘤的临床诊疗及研究进展[J].中华眼科杂志,2023,59(5):415-419.
REN TT,MA JM.Clinical diagnosis and treatment of optic nerve glioma:a review[J].Chin J Ophthalmol,2023,59(5):415-419.
[15] HUANG M,PATEL J,PATEL BC.Optic nerve sheath meningioma [DB/OL].In:StatPearls.Treasure Island (FL):StatPearls Publishing,2022 (2022-8-8)[2023-8-22].https://www.ncbi.nlm.nih.gov/books/ NBK430868.PMID:28613618.
[16]刘祎,姜利斌.视神经鞘脑膜瘤诊治中的误区与争议[J].中华眼底病杂志,2021,37(10):817-820.
LIU Y,JIANG LB.Misunderstandings and controversies in the diagnosis and treatment of optic nerve sheath meningioma[J].Chin J Ocul Fundus Dis,2021,37(10):817-820.
[17] PAKER RT,ONENS CA,FRASER CL,et al.Optic nerve sheath meningiomas:prevalence,impact,and management strategies[J].Eye Brain,2018,24(10):85-99.
[18] FRISEN L,ROYT WF,TENGROTH BM.Optociliary veins,disc pallor and visual loss.A triad of signs indicating spheno-orbital meningioma[J].Acta Ophthalmol (Copenh),1973,51(2):241-249.
[19]THOMAS J,CUMMING S.Ophthalmic pathology.A concise guide[DB/OL].New York:Springer Science& Business Media,2013:155(2023-4-12)[2023-8-22].https://link.springer.com/book/10.1007/978-1-4614-4394-0.DOI:10.1007/978-1-4614-4394-0.
[20] 刘洋,张虹,刘琳,等.视神经肿瘤36例临床分析[J].国际眼科杂志,2012,12(4):713-715.
LIU Yang,ZHANG Hong,LIU Lin,et al.Clinical analysis of 36 cases of optic nerve tumor [J] .International Journal of Ophthalmology,2012,12(4):713-715.
[21] SAKATA K,TAKESHIGE N,NAGATA Y,et al.Endoscopic endonasal removal of primary/recurrent meningiomas in the medial optic canal:surgical technique and long-term visual outcome [J].Oper Neurosurg (Hagerstown),2019,17(5):470-480.
[22] AMOLI FA,MEHRABANI PM,TARI AS.Aggressive orbital optic nerve meningioma with benign microscopic features:a case report[J].Orbit,2007,26(4):271-274.
[23] ZHU X,CHEN Z,LI X.Diosgenin inhibits the proliferation,migration and invasion of the optic nerve sheath meningioma cells via induction of mitochondrial-mediated apoptosis,autophagy and G0/G1 cell cycle arrest[J].J BUON,2020,25(1):508-513.
[24] ZENG C,GUO B,CHEN J,et al.Antitumor effects of chrysophanol in malignant optic nerve meningioma cell lines are mediated via Caspase activation,induction of mitochondrial mediated apoptosis,mitochondrial membrane depolarization and targeting the mitogen-activated protein kinase signaling pathway[J].Pharmacology,2019,104(1-2):28-35.